Adage Capital Advisors, L.L.C.
CIK 1403403 · last filed 2023-05-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RPRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
52ND FLOOR
BOSTON, MA 02116
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GCM Grosvenor Inc. (GCMGW) Delisted | 10%+ Owner | 4,526,021 | $0.01 | $43.0K | -$46.46M | 2 | 2023-05-05 |
| Abacus Global Management, Inc. (ERESW) Delisted | 10%+ Owner | 0 | $0.28 | $0 | $0 | 1 | 2023-01-24 |
| RPRX | 10%+ Owner | 38,714,280 | $63.62 | $2.46B | -$1.60B | 1 | 2020-12-18 |
| ADVENT TECHNOLOGIES HOLDINGS, INC. (AMCIW) Delisted | 10%+ Owner | 1,350,000 | $0.33 | $445.6K | -$61.44M | 1 | 2020-12-03 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | 10%+ Owner | 4,100,043 | — | — | -$12.90M | 1 | 2017-10-12 |
| PBYI | 10%+ Owner | 5,491,653 | $11.17 | $61.34M | -$400.82M | 4 | 2017-05-26 |
| Calithera Biosciences, Inc. (CALA) Delisted | 10%+ Owner | 181,753 | $0.00 | $55 | $7.88M | 1 | 2016-11-17 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | 10%+ Owner | 5,139,366 | — | — | $25.68M | 1 | 2015-02-20 |
| Nexvet Biopharma plc (NVET) Delisted | 10%+ Owner | 875,000 | — | — | $13.75M | 1 | 2015-02-10 |
| BOULDER BRANDS, INC. (SMBL) Delisted | 10%+ Owner | 6,563,680 | — | — | -$14.02M | 1 | 2013-01-02 |
| Sleep Number Corp (SCSS) Delisted | 10%+ Owner | 5,778,000 | — | — | -$16.28M | 1 | 2011-02-08 |
| Cardiome Pharma Corp (CRME) Delisted | 10%+ Owner | 7,850,000 | — | — | $19.60M | 1 | 2009-04-13 |
| HUBBELL INC (HUB.B) Delisted | 724,000 | — | — | -$742.5K | 1 | 2008-04-28 |
Recent Filings · Page 2 of 2
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-10 | Nexvet Biopharma plc (NVET) Delisted | Mixed | +4,375,000 | $13.75M | EDGAR |
| 2013-01-02 | BOULDER BRANDS, INC. (SMBL) Delisted | Sell (S) | −1,089,200 | -$14.02M | EDGAR |
| 2012-12-20 | PBYI | Buy (P) | +147,800 | $2.81M | EDGAR |
| 2012-12-11 | PBYI | Buy (P) | +700,200 | $13.29M | EDGAR |
| 2012-10-22 | PBYI | Buy (P) | +3,050,000 | $48.80M | EDGAR |
| 2012-07-27 | — | Buy (P) | +2,327,000 | $29.05M | |
| 2012-05-01 | — | Buy (P) | +610,975 | $8.37M | |
| 2011-02-08 | Sleep Number Corp (SCSS) Delisted | Sell (S) | −1,596,000 | -$16.28M | EDGAR |
| 2009-04-13 | Cardiome Pharma Corp (CRME) Delisted | Buy (P) | +5,000,000 | $19.60M | EDGAR |
| 2008-04-28 | HUBBELL INC (HUB.B) Delisted | Sell (S) | −15,000 | -$742.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.